# ADVERUM BIOTECHNOLOGIES INC (ADVM)

> Institutional ownership reported to the SEC as of Q3 2025, from Form 13F filings. Source: https://holderbook.com/stocks/ADVM/

- Reporting holders: 51
- Reported value: $64.3M
- Held through calls: 0.3%
- Held through puts: 0.5%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [BML Capital Management, LLC](https://holderbook.com/funds/1616824-bml-capital-management-llc/) | $13.9M | 3,057,526 | 12.7% | 7 |
| [Principia Wealth Advisory, LLC](https://holderbook.com/funds/2041436-principia-wealth-advisory-llc/) | $9.4M | 2,077,946 | 6.5% | 4 |
| [Frazier Life Sciences Management, L.P.](https://holderbook.com/funds/1892134-frazier-life-sciences-management-l-p/) | $9.4M | 2,077,431 | 0.3% | 6 |
| [TCG Crossover Management, LLC](https://holderbook.com/funds/1839948-tcg-crossover-management-llc/) | $7.6M | 1,668,174 | 0.4% | 5 |
| [VANGUARD GROUP INC](https://holderbook.com/funds/102909-vanguard-group-inc/) | $4.0M | 872,041 | 0.0% | 7 |
| [5AM Venture Management, LLC](https://holderbook.com/funds/1799883-5am-venture-management-llc/) | $2.5M | 541,666 | 0.9% | 7 |
| [Versant Venture Management, LLC](https://holderbook.com/funds/1560009-versant-venture-management-llc/) | $2.3M | 506,821 | 1.1% | 23 |
| [GOLDMAN SACHS GROUP INC](https://holderbook.com/funds/886982-goldman-sachs-group-inc/) | $1.8M | 402,581 | 0.0% | 6 |
| [RENAISSANCE TECHNOLOGIES LLC](https://holderbook.com/funds/1037389-renaissance-technologies-llc/) | $1.6M | 363,496 | 0.0% | 7 |
| [Pale Fire Capital SE](https://holderbook.com/funds/1922318-pale-fire-capital-se/) | $1.6M | 363,282 | 0.2% | 5 |
| [MILLENNIUM MANAGEMENT LLC](https://holderbook.com/funds/1273087-millennium-management-llc/) | $1.5M | 324,422 | 0.0% | 2 |
| [BlackRock, Inc.](https://holderbook.com/funds/2012383-blackrock-inc/) | $1.4M | 311,394 | 0.0% | 5 |
| [Soleus Capital Management, L.P.](https://holderbook.com/funds/1802630-soleus-capital-management-l-p/) | $1.3M | 287,246 | 0.1% | 6 |
| [DIMENSIONAL FUND ADVISORS LP](https://holderbook.com/funds/354204-dimensional-fund-advisors-lp/) | $1.1M | 234,541 | 0.0% | 7 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $837.3K | 184,762 | 0.0% | 7 |
| [REGENERON PHARMACEUTICALS, INC.](https://holderbook.com/funds/872589-regeneron-pharmaceuticals-inc/) | $819.5K | 180,909 | 0.1% | 4 |
| [Waverly Advisors, LLC](https://holderbook.com/funds/1568787-waverly-advisors-llc/) | $729.3K | 160,991 | 0.0% | 3 |
| [TWO SIGMA INVESTMENTS, LP](https://holderbook.com/funds/1179392-two-sigma-investments-lp/) | $401.7K | 88,670 | 0.0% | 2 |
| [STATE STREET CORP](https://holderbook.com/funds/93751-state-street-corp/) | $311.4K | 68,734 | 0.0% | 7 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](https://holderbook.com/funds/1446194-susquehanna-international-group-llp/) | $260.3K | 26,255 | 0.0% | 3 |
| [Quinn Opportunity Partners LLC](https://holderbook.com/funds/1633275-quinn-opportunity-partners-llc/) | $187.6K | 41,418 | 0.0% | 7 |
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $187.4K | 17,267 | 0.0% | 6 |
| [SIMPLEX TRADING, LLC](https://holderbook.com/funds/1488542-simplex-trading-llc/) | $177.0K | 0 | 0.0% | 1 |
| [TWO SIGMA ADVISERS, LP](https://holderbook.com/funds/1478735-two-sigma-advisers-lp/) | $172.5K | 38,071 | 0.0% | 2 |
| [MARSHALL WACE, LLP](https://holderbook.com/funds/1318757-marshall-wace-llp/) | $128.5K | 28,367 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2025 | 51 | $64.3M |
| Q2 2025 | 60 | $30.1M |
| Q1 2025 | 72 | $69.9M |
| Q4 2024 | 68 | $74.2M |
| Q3 2024 | 77 | $120.6M |
| Q2 2024 | 69 | $121.1M |
| Q1 2024 | 61 | $256.2M |
| Q4 2023 | 60 | $52.2M |
| Q3 2023 | 63 | $98.4M |
| Q2 2023 | 59 | $104.5M |
| Q1 2023 | 56 | $50.6M |
| Q4 2022 | 61 | $34.0M |